Last reviewed · How we verify
NCT07287774
Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids
NA trial testing Hearing Aid Noise Reduction - Off in Hearing Loss, Cochlear in 50 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Purdue University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 16 October 2025 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hearing Aid Noise Reduction - Off
- Hearing Aid Noise Reduction - Low
- Hearing Aid Noise Reduction - High
- Negative SNR
- Zero signal-to-noise ratio
- Positive SNR
Conditions studied
- Hearing Loss, Cochlear — all drugs for Hearing Loss, Cochlear →
Sponsor
Purdue University
Who can join
18 and older, any sex, with Hearing Loss, Cochlear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to understand how different hearing-aid noise-reduction technologies affect a listener's ability to hear speech in noisy environments. Participants will listen to speech at several background-noise levels while trying different processing settings. By comparing performance across these conditions, the study aims to identify which types of noise reduction improve speech intelligibility the most. We expect that some noise-reduction strategies will help listeners understand speech better than others, especially in more difficult listening situations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07287774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Cochlear
Currently open trials in the same condition.
- NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
Other Purdue University trials
Trials by the same sponsor.
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
- NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
- NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting
- NCT06596967 — Heat Therapy in Type 2 Diabetes · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07287774 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Purdue University
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07287774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing